Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 4 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Zai Lab Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 176
- −29 vs. Q4 2021
- Shares held
- 61.8M
- −2.85M (−4.4%) vs. Q4 2021
- Total value
- $2.71B
- −$1.35B (−33.3%) vs. Q4 2021
- New holders
- 21
- 62 more added
- Sold out
- 50
- 62 more reduced
2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZLAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $819.0M |
| Q1 2026 | 99 | $530.9M |
| Q4 2025 | 126 | $510.5M |
| Q3 2025 | 138 | $1.19B |
| Q2 2025 | 156 | $1.49B |
| Q1 2025 | 160 | $1.97B |
| Q4 2024 | 131 | $1.48B |
| Q3 2024 | 104 | $1.09B |
| Q2 2024 | 105 | $702.4M |
| Q1 2024 | 117 | $659.7M |
| Q4 2023 | 124 | $1.12B |
| Q3 2023 | 122 | $954.6M |
| Q2 2023 | 138 | $1.19B |
| Q1 2023 | 161 | $1.76B |
| Q4 2022 | 167 | $1.78B |
| Q3 2022 | 171 | $2.03B |
| Q2 2022 | 166 | $2.09B |
| Q1 2022 | 176 | $2.71B |
| Q4 2021 | 207 | $4.06B |
| Q3 2021 | 228 | $6.76B |
| Q2 2021 | 234 | $11.0B |
| Q1 2021 | 222 | $7.24B |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Zai Lab Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −8,914−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −8,761−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −8,193−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −6,702−100.0% | Sold out |
| Long Corridor Asset Management Ltd | 0 | $0 | 0.00% | −6,700−100.0% | Sold out |
| PEAK6 Investments LLC | 0 | $0 | 0.00% | −4,981−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −4,674−100.0% | Sold out |
| FORA Capital, LLC | 0 | $0 | 0.00% | −4,576−100.0% | Sold out |
| Seven Eight Capital, LP | 0 | $0 | 0.00% | −4,409−100.0% | Sold out |
| Envestnet Asset Management Inc | 0 | $0 | 0.00% | −3,775−100.0% | Sold out |
| Crossmark Global Holdings, Inc. | 0 | $0 | 0.00% | −3,710−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −2,449−100.0% | Sold out |
| Tobam | 0 | $0 | 0.00% | −1,300−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −673−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −503−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −274−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −220−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −131−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −56−100.0% | Sold out |
| Patriot Financial Group Insurance Agency, LLC | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Private Capital Group, LLC | 0 | $0 | 0.00% | −21−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Eagle Bay Advisors LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| RGT Wealth Advisors, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Andra AP-fonden | – | – | – | – | Not filed |
| Bell Investment Advisors, Inc | – | – | – | – | Not filed |